Diamicron MR 60 mg

Gliclazide is an oral medication belonging to the class of sulfonylurea antidiabetic drugs used primarily to treat type 2 diabetes mellitus. It works by stimulating the release of insulin from the pancreas, thereby lowering blood glucose levels. Gliclazide helps improve glycemic control by enhancing the body’s ability to utilize glucose effectively, which in turn reduces the risk of complications associated with uncontrolled diabetes, such as kidney damage, nerve damage, and cardiovascular disease. Additionally, Gliclazide has been shown to have beneficial effects on lipid metabolism, leading to reductions in triglyceride levels and improvements in lipid profiles.

One of the key benefits of Gliclazide is its ability to effectively lower blood sugar levels, leading to improved overall glycemic control and reduced risk of diabetes-related complications. It is often prescribed as a first-line treatment for type 2 diabetes, either alone or in combination with other antidiabetic medications, such as metformin or insulin, depending on individual patient needs. Gliclazide is generally well-tolerated, with a low risk of hypoglycemia when used at appropriate doses. However, like other sulfonylureas, it may cause side effects such as weight gain, gastrointestinal disturbances, and skin reactions in some individuals.